Lilly's Strong Earnings Ease Concerns Over GLP-1 Pricing Pressures | Retatrutide News

Eli Lilly's earnings exceeded expectations, easing GLP-1 pricing concerns. The report underscores Lilly's resilience in the competitive metabolic market.
Market News · October 31, 2026